These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 36071748)

  • 1. Translocator Protein 18 kDa (TSPO) as a Novel Therapeutic Target for Chronic Pain.
    Liu J; Huang J; Zhang Z; Zhang R; Zhang Z; Liu Y; Ma B
    Neural Plast; 2022; 2022():8057854. PubMed ID: 36071748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Ligands of Translocator Protein: Design and Biological Properties.
    Mokrov GV; Deeva OA; Gudasheva TA
    Curr Pharm Des; 2021; 27(2):217-237. PubMed ID: 32881658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An update into the medicinal chemistry of translocator protein (TSPO) ligands.
    Barresi E; Robello M; Costa B; Da Pozzo E; Baglini E; Salerno S; Da Settimo F; Martini C; Taliani S
    Eur J Med Chem; 2021 Jan; 209():112924. PubMed ID: 33081988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of the mitochondrial permeability transition pore by the outer membrane does not involve the peripheral benzodiazepine receptor (Translocator Protein of 18 kDa (TSPO)).
    Šileikytė J; Blachly-Dyson E; Sewell R; Carpi A; Menabò R; Di Lisa F; Ricchelli F; Bernardi P; Forte M
    J Biol Chem; 2014 May; 289(20):13769-81. PubMed ID: 24692541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mitochondrial translocator protein (TSPO): a key multifunctional molecule in the nervous system.
    El Chemali L; Akwa Y; Massaad-Massade L
    Biochem J; 2022 Jul; 479(13):1455-1466. PubMed ID: 35819398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural requirements to obtain highly potent and selective 18 kDa Translocator Protein (TSPO) Ligands.
    Taliani S; Pugliesi I; Da Settimo F
    Curr Top Med Chem; 2011; 11(7):860-86. PubMed ID: 21291396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Translocator protein as a promising target for novel anxiolytics.
    Costa B; Da Pozzo E; Martini C
    Curr Top Med Chem; 2012; 12(4):270-85. PubMed ID: 22204481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of TSPO ligands on mitochondrial function in mouse microglia cells.
    Bader S; Wolf L; Milenkovic VM; Gruber M; Nothdurfter C; Rupprecht R; Wetzel CH
    Psychoneuroendocrinology; 2019 Aug; 106():65-76. PubMed ID: 30954920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting mitochondrial energy metabolism with TSPO ligands.
    Gut P
    Biochem Soc Trans; 2015 Aug; 43(4):537-42. PubMed ID: 26551690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The changing landscape in translocator protein (TSPO) function.
    Selvaraj V; Stocco DM
    Trends Endocrinol Metab; 2015 Jul; 26(7):341-8. PubMed ID: 25801473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Translocator Protein 18 kDa (TSPO): An Old Protein with New Functions?
    Li F; Liu J; Liu N; Kuhn LA; Garavito RM; Ferguson-Miller S
    Biochemistry; 2016 May; 55(20):2821-31. PubMed ID: 27074410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The translocator protein (TSPO): a novel target for cancer chemotherapy.
    Austin CJ; Kahlert J; Kassiou M; Rendina LM
    Int J Biochem Cell Biol; 2013 Jul; 45(7):1212-6. PubMed ID: 23518318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the Translocator Protein (18 kDa) in Cardiac Diseases: State of the Art and Future Opportunities.
    Baglini E; Poggetti V; Cavallini C; Petroni D; Forini F; Nicolini G; Barresi E; Salerno S; Costa B; Iozzo P; Neglia D; Menichetti L; Taliani S; Da Settimo F
    J Med Chem; 2024 Jan; 67(1):17-37. PubMed ID: 38113353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spinal translocator protein alleviates chronic neuropathic pain behavior and modulates spinal astrocyte-neuronal function in rats with L5 spinal nerve ligation model.
    Liu X; Liu H; Xu S; Tang Z; Xia W; Cheng Z; Li W; Jin Y
    Pain; 2016 Jan; 157(1):103-116. PubMed ID: 26307860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular cholesterol changes induced by translocator protein (18 kDa) TSPO/PBR ligands.
    Falchi AM; Battetta B; Sanna F; Piludu M; Sogos V; Serra M; Melis M; Putzolu M; Diaz G
    Neuropharmacology; 2007 Aug; 53(2):318-29. PubMed ID: 17631921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders.
    Rupprecht R; Papadopoulos V; Rammes G; Baghai TC; Fan J; Akula N; Groyer G; Adams D; Schumacher M
    Nat Rev Drug Discov; 2010 Dec; 9(12):971-88. PubMed ID: 21119734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The translocator protein (18kDa) and its role in neuropsychiatric disorders.
    Barichello T; Simões LR; Collodel A; Giridharan VV; Dal-Pizzol F; Macedo D; Quevedo J
    Neurosci Biobehav Rev; 2017 Dec; 83():183-199. PubMed ID: 29054730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the 18-kDa translocator protein: recent perspectives for neuroprotection.
    Da Pozzo E; Giacomelli C; Barresi E; Costa B; Taliani S; Passetti Fda S; Martini C
    Biochem Soc Trans; 2015 Aug; 43(4):559-65. PubMed ID: 26551693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [18 kDa translocator protein--implications in cell's functions].
    Kołodziejczyk A
    Postepy Hig Med Dosw (Online); 2015 Jan; 69():34-50. PubMed ID: 25589712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Channel-like functions of the 18-kDa translocator protein (TSPO): regulation of apoptosis and steroidogenesis as part of the host-defense response.
    Veenman L; Papadopoulos V; Gavish M
    Curr Pharm Des; 2007; 13(23):2385-405. PubMed ID: 17692008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.